Siklos® (hydroxyurea) now available through ProCare Pharmacy Care's Siklos At Home™ program
Published: Sep 12, 2018
ROSEMONT, PA, Sept. 12, 2018 /PRNewswire/ - Medunik USA announced today that Siklos® (hydroxyurea), the first and only hydroxyurea-based treatment FDA-approved for pediatric patients with sickle cell anemia, is now available through the Siklos At Home™ program.
"The recent launch of Siklos® represents an important milestone in Medunik USA's mission to support patients with rare diseases - in this case, sickle cell anemia," said Dean Hopkins, the company's General Manager. "We are looking forward to introducing this treatment to pediatric patients with sickle cell anemia and committed to providing Siklos® at the lowest possible cost to all patients, whether they are cash-paying or have commercial or Medicaid healthcare coverage, through the Siklos At Home™ program, offered through our specialty pharmacy, ProCare Pharmacy Care."
Through Siklos At Home™, commercially insured patients can receive Siklos® for as little as $0 copay per prescription. Patients who are not insured or whose insurance does not cover Siklos® can pay as little as $99 for 60 tablets or $149 for 90 tablets.
In addition to providing savings on the cost of a prescription, the Siklos At Home™ program offers home delivery at no additional charge, as well as insurance benefit verification, monthly refill reminders, prior authorization support and pharmacists to answer product questions.
For physicians' offices, the Siklos At Home™ program offers the convenience of patient benefit verification, assistance with prior authorizations, monthly refill reminders for patients, as well as three easy ways to prescribe Siklos®: by telephone, by fax or by e-prescription.
Children with sickle cell anemia have abnormal red blood cells that become stuck in the blood vessels, blocking blood flow. These blockages can cause crippling pain and organ damage, which begins early in life and worsens over time.1 That is why early treatment and a medication like Siklos®, specifically indicated for a pediatric population, are so important.
Siklos® is a prescription medicine that is used to reduce the frequency of painful crises and reduce the need for blood transfusions in children, 2 years of age and older, with sickle cell anemia with recurrent moderate to severe painful crises.2
Thanks to the Siklos At Home™ program, filling a prescription for Siklos® is now more affordable and convenient for families whose time and resources are best spent caring for their child.
Siklos® is a prescription medicine that is used to reduce the frequency of painful crises and reduce the need for blood transfusions in children, 2 years of age and older, with sickle cell anemia with recurrent moderate to severe painful crises. It is not known if Siklos® is safe and effective in children less than 2 years of age.
WARNING: LOW BLOOD CELL COUNT and CANCER
WHAT IS THE MOST IMPORTANT INFORMATION YOU SHOULD KNOW ABOUT SIKLOS®?
WHO SHOULD NOT TAKE SIKLOS®?
Siklos® may cause serious side effects, including skin ulcers (including leg ulcers) and enlarged red blood cells (macrocytosis).
The most common side effects of Siklos® include: infections, headache, fever, skin problems, stomach and intestine problems, decrease in vitamin D and weight gain. These are not all the possible side effects of Siklos®.
Please consult full Prescribing Information, including Boxed Warning.
For more information about Siklos®, we invite you to contact our Medical Information Service at 1 844-884-5520 or https://www.medunikusa.com/en/medical-information-service
About Sickle Cell Anemia
About Medunik USA
1 Platt, OS and al., Mortality in sickle cell disease. Life expectancy and risk factors for early death., N Engl J Med. 1994 Jun 9;330(23):1639-44. 2 Siklos(R) (hydroxyurea) tablets, for oral use [Prescribing Information]. Addmedica, May 2018. 3 Sickle Cell Disease, <https://www.nhlbi.nih.gov/health-topics/sickle- cell-disease>
View original content to download multimedia:http://www.prnewswire.com/news-releases/siklos-hydroxyurea-now-available-through-procare-pharmacy-cares-siklos-at-home-program-300710740.html
SOURCE Medunik USA